Скачать с ютуб How are core Therapeutic Areas central to Novartis strategy? в хорошем качестве

How are core Therapeutic Areas central to Novartis strategy?

Novartis is transforming into a ‘pure-play’ Innovative Medicines company. Our focused strategy, differentiated pipeline and strong global footprint are central to becoming the most valued and trusted medicines company in the world. In a recent Meet Novartis Management Investor Relations session, Vas Narasimhan, Novartis Chief Executive Officer shares more on how this new strategy provides a focus on core therapeutic areas (Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology). Meet Novartis Management Event Date: September 22, 2022 Investors Page: https://bit.ly/3QVeG2k Link to Novartis Strategy: https://bit.ly/3D2sl1V Disclaimer: Meet Novartis Management event contains forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information: https://bit.ly/3HiI7IO Follow @Novartis on Twitter:   / novartis   Follow Novartis on LinkedIn:   / novartis